Medigen Vaccine Biologics Corporation apply for Emergency Use Authorization (EUA) in various countries; pursue relative clinical studies and post-marketing surveillance. TGA is very convincing in global pharmaceutical regulatory authorities. It is not only one of the Stringent Regulatory Authority (SRA) defined by WHO, but also one of the top ten advanced medical countries in Taiwan's Regulations for Medicinal Products Registration.

In the process of formulating international medical regulations for COVID-19, TGA is also the members of ”International Coalition of Medicines Regulatory Authorities (ICMRA)”, ”Access Consortium”, and ”COVID-19 Vaccines and Therapeutics Committee of EMA”.